Susan VanMeter

740 citations

16 papers · 511 indexed · h-index 8

Biological Psychiatry top 5%
Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases 2
Psychiatry and Mental health top 10%
- Electroconvulsive Therapy Studies 2
Pathology and Forensic Medicine top 10%
- Multiple Sclerosis Research Studies 3
Neurology
- Parkinson's Disease Mechanisms and Treatments 4
- Neurological disorders and treatments 3
Epidemiology
- Neuroendocrine Tumor Research Advances 2
Genetics
- Chronic Lymphocytic Leukemia Research 2
Gastroenterology
- Gastrointestinal Tumor Research and Treatment 2

Co-authors: Jack G. Modell Carol B. Rockett Michael E. Thase Barbara R. Haight Nathalie Richard Amit Bar‐Or Richard Grove Daren Austin
Cited by: Biological Psychiatry Pharmacology Psychiatry and Mental health
Journals: Neurology (7 papers)The Journal of Clinical Psychiatry (2 papers)Clinical Therapeutics (1 paper)
Partner nations: United States United Kingdom Canada

In The Last Decade

Susan VanMeter

12 papers receiving 486 citations

Peers

Countries citing papers authored by Susan VanMeter

Since Specialization

Citations

This map shows the geographic impact of Susan VanMeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan VanMeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan VanMeter more than expected).

Fields of papers citing papers by Susan VanMeter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan VanMeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan VanMeter. The network helps show where Susan VanMeter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Susan VanMeter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Susan VanMeter Line = papers co-authored together Susan VanMeter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Pyrimidine Nucleos(t)ide Therapy in Patients With Thymidine Kinase 2 Deficiency Neurology ·Cristina Domínguez‐González,Carl Chiang,Anny‐Odile Colson,M. Hasan,(unknown),Joanne Quan,Susan VanMeter,Michio Hirano	2025	0
2	The Disease Course of Untreated Patients with Thymidine Kinase 2 Deficiency (TK2d) Aged ≤12 Years at TK2d Symptom Onset: Findings from the Largest International TK2d Dataset (P10-6.007) Neurology ·Michio Hirano,A. Nascimento Osorio,Yuanjun Ma,Nada Boudiaf,Richard Kim,Susan VanMeter,S N Iype,Cristina Domínguez‐González	2025	0
3	The Disease Course of Untreated Patients with Thymidine Kinase 2 Deficiency (TK2d) Aged >12 Years at TK2d Symptom Onset: Findings from the Largest International TK2d Dataset (P2-11.020) Neurology ·Cristina Domínguez‐González,A. Nascimento Osorio,Yuanjun Ma,Nada Boudiaf,Richard Kim,Susan VanMeter,S N Iype,Michio Hirano	2025	0
4	Pharmacokinetics and Safety of a 1:1 Mixture of Doxecitine and Doxribtimine: Open-label Phase 1 Single Ascending Dose and Food Effect Studies in Healthy Adults Clinical Therapeutics ·Bose System,Susan VanMeter,Christoph Hagena,E.A. Averin	2024	0
5	Prevalence of Hepatic Encephalopathy from a Commercial Medical Claims Database in the United States International Journal of Hepatology ·Philipe Rego,Susan VanMeter,Jan Stange	2021	9
6	Post hoc analysis using PRO-ACT database to evaluate Repository Corticotropin Injection (H.P. Acthar® Gel) as a potential treatment for ALS (P5.327) Neurology ·Susan VanMeter,Patrice M. Becker,Lester Mackey,Wu Mingzhang,Tsz Wai Li	2018	2
7	Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis Neurology ·Amit Bar‐Or,Richard Grove,Daren Austin,Jerry M. Tolson,Susan VanMeter,Eric Lewis,Frederick J. Derosier,Valter Haglund,Sarah Kavanagh,Aaron Miller,Per Soelberg Sørensen	2018	154
8	A randomized, fixed-dose, dose–response Study of Ropinirole Prolonged Release in Advanced Parkinson’s Disease Neurodegenerative Disease Management ·Theresa A. Zesiewicz,A. de Haar-Holleman,R P Berko,Serena Virdi,Ana Idžanović,Susan VanMeter	2017	12
9	A fixed-dose, dose–response Study of Ropinirole Prolonged Release in Early Stage Parkinson’s Disease Neurodegenerative Disease Management ·Theresa Zesiewicz,A. de Haar-Holleman,R P Berko,Serena Virdi,Susan VanMeter	2017	7
10	Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson's disease International Journal of Neuroscience ·Alberto De Longhi,Maxwell F Lydiatt,Jeffrey J. Ellis,Lutfi Variska Putri,Amirthvarshan Yogesh C,Susan VanMeter	2014	9
11	The MIRROR Study: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Investigate the Safety and MRI Efficacy of Subcutaneous Ofatumumab in Subjects with Relapsing-Remitting Multiple Sclerosis (RRMS) (S23.006) Neurology ·Amit Bar‐Or,Richard Grove,Daren Austin,Jerry M. Tolson,Susan VanMeter,Juan David Paz Benavides,Gautam Das	2014	22
12	The MIRROR Study: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Investigate the Safety and MRI Efficacy of Subcutaneous Ofatumumab in Subjects with Relapsing-Remitting Multiple Sclerosis (RRMS) (I7-1.007) Neurology ·Amit Bar‐Or,Richard Grove,Daren Austin,Jerry M. Tolson,Susan VanMeter,Juan David Paz Benavides,Gautam Das	2014	3
13	Su1057 The Burden of Comedication Among Inflammatory Bowel Disease Patients Gastroenterology ·Jessie P. Buckley,Michael D. Kappelman,Jeffery K. Allen,Susan VanMeter,Suzanne F. Cook	2013	1
14	Dose Response of Gabapentin Enacarbil versus Placebo in Subjects with Moderate-to-Severe Primary Restless Legs Syndrome CNS Drugs ·Susan VanMeter,Sarah Kavanagh,Lin Hui,Ronald W. Barrett	2012	15
15	Extended-Release Bupropion for Patients With Major Depressive Disorder Presenting With Symptoms of Reduced Energy, Pleasure, and Interest The Journal of Clinical Psychiatry ·James W. Jefferson,A. John Rush,J. Craig Nelson,Susan VanMeter,Alok Krishen,Kenneth D. Hampton,Saadet Gül,Jack G. Modell	2006	42
16	Remission Rates Following Antidepressant Therapy With Bupropion or Selective Serotonin Reuptake Inhibitors The Journal of Clinical Psychiatry ·Michael E. Thase,Barbara R. Haight,Nathalie Richard,Carol B. Rockett,Hans Peter Schmidli,Jack G. Modell,Susan VanMeter,Rupesh Wankar,Prosanto Chaudhary	2005	235

About Susan VanMeter

Susan VanMeter is a scholar working on Neurology, Gastroenterology, Psychiatry and Mental health, Genetics and Pharmacology, having authored 16 papers that have together received 511 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (4 papers), Multiple Sclerosis Research Studies (3 papers), Neurological disorders and treatments (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Electroconvulsive Therapy Studies (2 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). The work is most often cited by research in Biological Psychiatry (72 citations), Pharmacology (172 citations), Psychiatry and Mental health (113 citations), Pathology and Forensic Medicine (133 citations) and Neurology (93 citations). Susan VanMeter has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jack G. Modell, Carol B. Rockett, Michael E. Thase, Barbara R. Haight, Nathalie Richard, Amit Bar‐Or, Richard Grove, Daren Austin, Sarah Kavanagh and Jerry M. Tolson. Their work appears in journals such as Neurology, The Journal of Clinical Psychiatry, Clinical Therapeutics, CNS Drugs and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact